Article: Effectively resolving IP disputes in the pharmaceutical industry

23.1.2014

The Acquisition International magazine interviewed Mr Folke Johansson, Director and European Patent Attorney, and Ms Erja Partio, European Patent Attorney, for an article about IP litigation in the pharmaceutical industry in Finland.

Read the report published in the Acquisition International January 2014 issue.

Effectively resolving IP disputes in the pharmaceutical industry

News

Papula-Nevinpat again recognized as one of Finland’s leading practises in the 2019 Edition of WTR 1000

In the survey taking place for the ninth year, Papula-Nevinpat was ranked in the Silver Category in the prosecution and strategy sector.

Supplementary protection certificate extends the patent term by up to five and a half years – but who’s entitled?

The term of a pharmaceutical or plant production patent can be extended by a maximum of 5 years, up to 25 years altogether. Who is entitled and under which conditions? To find out read the blog by our experts Katja Feiring and Erja Partio.

Folke Johansson, Markku Simmelvuo and Marina Smirnova listed as WIPR Leaders 2019

Folke Johansson, who heads our firm’s patent department, and Markku Simmelvuo, our Managing Director, were both ranked in the patent category in Finland. In Russia, Marina Smirnova was ranked in both the patent and trademark categories.

Technology hype disconnects businesses from the product development reality

Our CDO Teemu Lang is blogging about AI hype. Artificial intelligence, or machine-learning algorithms, is a technology that is disruptive to our business as well, and enables new products and business models.